Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Leconte

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
ERJ Open Research|April 25, 2017
MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosisYasmina Bauer, Eric S White, Simon de Bernard, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 3, 2010
MRI of iron-oxide labelled transplanted hepatocytes in mice: effect of treatment with cyclophosphamideIsabelle Leconte, Stéphane Pallu, Jorge Abarca-Quinones, et al.
Cancers|August 26, 2022
Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision MedicineFrançoise Derouane, Cédric van Marcke, Martine Berlière, et al.
Cancers|January 8, 2023
Effects of Hormones on Breast Development and Breast Cancer Risk in Transgender WomenMartine Berliere, Maximilienne Coche, Camille Lacroix, et al.
American Journal of Respiratory and Critical Care Medicine|September 29, 2007
BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosisTalmadge E King, Jürgen Behr, Kevin K Brown, et al.
Reproductive Toxicology (Elmsford, N.Y.)|March 17, 2019
A multi-institutional study benchmarking the zebrafish developmental assay for prediction of embryotoxic plasma concentrations from rat embryo-fetal development studiesSteven Cassar, Manon Beekhuijzen, Bruce Beyer, et al.
American Journal of Respiratory and Critical Care Medicine|April 9, 2011
BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosisTalmadge E King, Kevin K Brown, Ganesh Raghu, et al.
The New England Journal of Medicine|March 22, 2002
Bosentan therapy for pulmonary arterial hypertensionLewis J Rubin, David B Badesch, Robyn J Barst, et al.
Reproductive Toxicology (Elmsford, N.Y.)|March 1, 2026
IDENTIFYING AND REPORTING DYSTOCIA IN LABORATORY RODENTSPaul Barrow, Prägati S Coder, Rashin Ghaffari, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|May 25, 2012
Value of juvenile animal studiesIsabelle Leconte, Graham Bailey, Karen Davis-Bruno, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
ERJ Open Research|April 25, 2017
MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosisYasmina Bauer, Eric S White, Simon de Bernard, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 3, 2010
MRI of iron-oxide labelled transplanted hepatocytes in mice: effect of treatment with cyclophosphamideIsabelle Leconte, Stéphane Pallu, Jorge Abarca-Quinones, et al.
Cancers|August 26, 2022
Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision MedicineFrançoise Derouane, Cédric van Marcke, Martine Berlière, et al.
Cancers|January 8, 2023
Effects of Hormones on Breast Development and Breast Cancer Risk in Transgender WomenMartine Berliere, Maximilienne Coche, Camille Lacroix, et al.
American Journal of Respiratory and Critical Care Medicine|September 29, 2007
BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosisTalmadge E King, Jürgen Behr, Kevin K Brown, et al.
Reproductive Toxicology (Elmsford, N.Y.)|March 17, 2019
A multi-institutional study benchmarking the zebrafish developmental assay for prediction of embryotoxic plasma concentrations from rat embryo-fetal development studiesSteven Cassar, Manon Beekhuijzen, Bruce Beyer, et al.
American Journal of Respiratory and Critical Care Medicine|April 9, 2011
BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosisTalmadge E King, Kevin K Brown, Ganesh Raghu, et al.
The New England Journal of Medicine|March 22, 2002
Bosentan therapy for pulmonary arterial hypertensionLewis J Rubin, David B Badesch, Robyn J Barst, et al.
Reproductive Toxicology (Elmsford, N.Y.)|March 1, 2026
IDENTIFYING AND REPORTING DYSTOCIA IN LABORATORY RODENTSPaul Barrow, Prägati S Coder, Rashin Ghaffari, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|May 25, 2012
Value of juvenile animal studiesIsabelle Leconte, Graham Bailey, Karen Davis-Bruno, et al.
Pageof 3